CA3022586A1 - Markers of endometrial cancer - Google Patents

Markers of endometrial cancer Download PDF

Info

Publication number
CA3022586A1
CA3022586A1 CA3022586A CA3022586A CA3022586A1 CA 3022586 A1 CA3022586 A1 CA 3022586A1 CA 3022586 A CA3022586 A CA 3022586A CA 3022586 A CA3022586 A CA 3022586A CA 3022586 A1 CA3022586 A1 CA 3022586A1
Authority
CA
Canada
Prior art keywords
ldha
mmp9
level
nampt
kpym
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3022586A
Other languages
English (en)
French (fr)
Inventor
Elena Martinez Garcia
Eva Colas Ortega
Antonio Gil Moreno
Jaume Reventos Puigjaner
Bruno Domon
Antoine LESUR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacio Institut de Recerca Hospital Universitari Vall dHebron
Original Assignee
Institut De Recerca Biomedica De Lleida Fundacio Dr Pifarre
Fundacio Institut de Recerca Hospital Universitari Vall dHebron
Luxembourg Institute of Health LIH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut De Recerca Biomedica De Lleida Fundacio Dr Pifarre, Fundacio Institut de Recerca Hospital Universitari Vall dHebron, Luxembourg Institute of Health LIH filed Critical Institut De Recerca Biomedica De Lleida Fundacio Dr Pifarre
Priority to CA3286798A priority Critical patent/CA3286798A1/en
Publication of CA3022586A1 publication Critical patent/CA3022586A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA3022586A 2016-05-04 2017-03-30 Markers of endometrial cancer Pending CA3022586A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3286798A CA3286798A1 (en) 2016-05-04 2017-03-30 Markers of endometrial cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16168328.9 2016-05-04
EP16168328 2016-05-04
PCT/EP2017/057635 WO2017190896A1 (en) 2016-05-04 2017-03-30 Mmp9 as marker of endometrial cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3286798A Division CA3286798A1 (en) 2016-05-04 2017-03-30 Markers of endometrial cancer

Publications (1)

Publication Number Publication Date
CA3022586A1 true CA3022586A1 (en) 2017-11-09

Family

ID=56096908

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3022586A Pending CA3022586A1 (en) 2016-05-04 2017-03-30 Markers of endometrial cancer
CA3286798A Pending CA3286798A1 (en) 2016-05-04 2017-03-30 Markers of endometrial cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3286798A Pending CA3286798A1 (en) 2016-05-04 2017-03-30 Markers of endometrial cancer

Country Status (11)

Country Link
US (2) US20190137499A1 (enExample)
EP (3) EP4180814B1 (enExample)
JP (3) JP7240712B2 (enExample)
AU (3) AU2017260806B9 (enExample)
CA (2) CA3022586A1 (enExample)
DK (1) DK3452829T3 (enExample)
ES (1) ES2974307T3 (enExample)
FI (1) FI3452829T3 (enExample)
PL (1) PL3452829T3 (enExample)
PT (1) PT3452829T (enExample)
WO (1) WO2017190896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3655778T3 (pl) * 2017-07-21 2023-09-18 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Agryna jako marker raka endometrium
AU2022315559A1 (en) * 2021-07-23 2024-02-15 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Biomarkers for endometrial cancer
CN113493838B (zh) * 2021-09-06 2021-11-23 北京泱深生物信息技术有限公司 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用
KR102640230B1 (ko) * 2021-09-24 2024-02-22 가천대학교 산학협력단 C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
EP1711618B1 (en) 2003-12-23 2010-08-04 Mount Sinai Hospital Corporation Methods for detecting markers associated with endometrial disease or phase
US20080090258A1 (en) * 2006-06-28 2008-04-17 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
EP2087152B1 (en) 2006-10-27 2015-03-11 Walfish, Paul Endometrial biomarkers
CA2767914C (en) * 2009-07-24 2020-02-25 Geadic Biotec, Aie. Markers for endometrial cancer

Also Published As

Publication number Publication date
AU2025223935A1 (en) 2025-09-18
AU2017260806B9 (en) 2023-07-20
PT3452829T (pt) 2024-03-22
JP7240712B2 (ja) 2023-03-16
EP3452829A1 (en) 2019-03-13
AU2017260806B2 (en) 2023-06-15
DK3452829T3 (da) 2024-03-25
JP2023040246A (ja) 2023-03-22
PL3452829T3 (pl) 2024-05-20
US20190137499A1 (en) 2019-05-09
US20230221323A1 (en) 2023-07-13
CA3286798A1 (en) 2025-10-30
JP2019516104A (ja) 2019-06-13
EP3452829B1 (en) 2024-01-24
EP4610655A3 (en) 2025-12-10
BR112018072498A2 (pt) 2019-03-12
AU2023210591B9 (en) 2025-07-10
AU2023210591A1 (en) 2023-08-24
AU2017260806A1 (en) 2018-12-13
AU2023210591B2 (en) 2025-06-26
EP4180814B1 (en) 2026-03-04
JP2024116127A (ja) 2024-08-27
EP4610655A2 (en) 2025-09-03
FI3452829T3 (fi) 2024-03-20
EP4180814A2 (en) 2023-05-17
ES2974307T3 (es) 2024-06-26
JP7492287B2 (ja) 2024-05-29
EP4180814A3 (en) 2023-07-12
JP7797770B2 (ja) 2026-01-14
EP4180814C0 (en) 2026-03-04
WO2017190896A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
AU2023210591B2 (en) Markers of endometrial cancer
US20240011994A1 (en) Ctnb1 as a marker for endometrial cancer
Chen et al. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia
TWI842716B (zh) 泌尿道上皮細胞癌生物標記及其應用
BR122025014970A2 (pt) Método e uso que compreendem kpym para o diagnóstico ou prognóstico de carcinoma endometrial, bem como kit para detectar o nível de expressão de kpym e outros marcadores
BR122023026792A2 (pt) Método e uso da combinação dos marcadores perm e clic1 como marcadores in vitro para diagnosticar ou prognosticar carcinoma endometrial, bem como kit para detectar nível de expressão proteica
BR112018072498B1 (pt) Método e uso in vitro que compreendem perm para o diagnóstico ou prognóstico de carcinoma endometrial
BR122024027006A2 (pt) Método para o diagnóstico de câncer endometrial em uma amostra de fluido uterino, kit e método implementado por computador para realizar o dito método diagnóstico e método para decidir ou recomendar um regime médico
Chen et al. Research Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220325

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20241010

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20241217

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20241217

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250327

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250327

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250327

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250414

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250728

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250808

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250929

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250929

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD

Year of fee payment: 9

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260310

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260310